Estrogen replacement therapy and asthma

Pulmonary Pharmacology and Therapeutics

Volumn 26, Issue 6, 2013, Pages 617-623

  Ticconi, Carlo ^a   Pietropolli, Adalgisa ^a   Piccione, Emilio ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Asthma; Estrogen; Hormone replacement therapy; Menopause

Indexed keywords

12 HYDROXYICOSATETRAENOIC ACID; CONJUGATED ESTROGEN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GLUCOCORTICOID RECEPTOR; GUANYLATE CYCLASE; HEAT SHOCK PROTEIN 90; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; LEUKOTRIENE E4; MITOGEN ACTIVATED PROTEIN KINASE; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; PROGESTERONE; REACTIVE OXYGEN METABOLITE;

ASTHMA; CLIMACTERIUM; ESTROGEN THERAPY; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; LUNG ALVEOLUS EPITHELIUM; MENOPAUSE; OXIDATIVE PHOSPHORYLATION; POSTMENOPAUSE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; RESPIRATORY FUNCTION; REVIEW; RISK FACTOR;

ASTHMA; ESTROGEN; HORMONE REPLACEMENT THERAPY; MENOPAUSE;

ANIMALS; ASTHMA; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HUMANS; LUNG; MENOPAUSE;

EID: 84887994425     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2013.08.004     Document Type: Review

References (86)

1. WHO GINA Report, Global Strategy for asthma Management and Prevention 2010, World Health Organization, Geneva, Switzerland.
2. Al-Mushen S., Johnson J.R., Hamid Q. Remodeling in asthma. JAllergy Clin Immunol 2011, 128:451-464.
3. Doeing D.C., Soway J. Airway smooth muscle in the pathophysiology and treatment of asthma. JAppl Physiol 2013, 114:834-843.
4. West A.R., Syyong H.T., Siddiqui S., Pascoe C.D., Murphy T.M., Maarsingh H., et al. Airway contractility and remodeling: link to asthma symptoms. Pulm Pharmacol Ther 2013, 26:3-12.
5. James A.L., Elliott J.G., Jones R.L., Carroll M.L., Mauad T., Bai T.R., et al. Airway smooth muscle hypertrophy and hyperplasia in asthma. Am J Respir Crit Care Med 2012, 185:1058-1064.
6. James A.L., Maxwell P.S., Pearce-Pinto G., Elliot J.G., Carroll N.G. The relationship of reticular basement membrane thickness to airway wall remodeling in asthma. Am J Respir Crit Care Med 2002, 166:1590-1595.
7. Holgate S.T. Abrief history of asthma and its mechanisms to modern concepts of disease pathogenesis. Allergy Asthma Immunol Res 2010, 2:165-171.
8. Khan M.A. Inflammation signals airway smooth muscle cell proliferation in asthma pathogenesis. Multidisciplinary Respir Med 2013, 8:1-5.
9. Tulic M.K., Christodoulopoulos P., Hamid Q. Small airway inflammation in asthma. Respir Res 2001, 2:333-339.
10. Howarth P.H., Babu K.D.S., Arshad H.S., Lau L., BuckleyM, McConnell W., et al. Tumour necrosis factor (TNFalpha) as a novel therapeutic target in symptomatic corticosteroid dependent asthma. Thorax 2005, 60:1012-1018.
11. Szefler S.J., Dakhama A. New insights into asthma pathogenesis and treatment. Curr Opin Immunology 2011, 23:801-807.
12. Schmidt P. The 2012 hormone therapy position statement of the North American menopause Society. Menopause 2012, 19:257-271.
13. Rossouw J.E., Prentice R.L., Manson J.E., Wu L., Barad D., Barnabei V.M., et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 2007, 297:1465-1477.
14. Wassertheil-Smoller S., Hendrix S.L., Limacher M., Heiss G., Kooperberg C., Baird A., et al. for the WHI Investigators. Effect of estrogen plus progestin on stroke in postmenopausal women. The women's Health Initiative: a randomized trial. JAMA 2003, 289:2673-2684.
15. Prentice R.L., Manson J.E., Langer R.D., Anderson G.L., Pettinger M., Jackson R.D., et al. Benefits and risks of postmenopausal hormone therapy when it is initiated soon after the menopause. Am J Epidemiol 2009, 170:12-23.
16. Canonico M., Oger E., Plu-Bureau G., Conard J., Meyer G., Lévesque H., et al. Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study. Circulation 2007, 115:840-845.
17. Beral V. Breast cancer and hormone replacement therapy in the Million women Study. Lancet 2003, 362:419-427. Million Women Collaborators.
18. Chlebowski R.T., Anderson G.L. Changing concepts: menopausal hormone therapy and breast cancer. JNatl Canc Inst 2012, 104:517-527.
19. Zhou B., Sun Q., Cong R., Gu H., Tang N., Yang L., et al. Hormone replacement therapy and ovarian cancer risk: a meta-analysis. Gynecol Oncol 2008, 108:641-651.
20. Grady D., Gebretsadik T., Kerlikowske K., Ernster V., Petitti D. Hormone replacement therapy and endometrial cancer risk: a meta-analysis. Obstet Gynecol 1995, 85:304-313.
21. Margolis K.L., Bonds D.E., Rodabough R.J., Tinker L., Phillips L.S., Allen c, et al. Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women; results from the Women's Health Initiative Hormone Trial. Diabetologia 2004, 47:1175-1187.
22. Slatore C.G., Chien J.W., Au D.H., Satia J.A., White E. Lung cancer and hormone replacement therapy: association in the vitamins and lifestyle study. JClin Oncol 2010, 28:1540-1546.
23. Oh S.W., Myung S.K., Park J.Y., Lym Y.L., Ju W. Hormone therapy and risk of lung cancer: a meta-analysis. JWomen Health 2010, 19:279-288.
24. Skobeloff E.M., Spivey W.H., St.Clair S.S., Schoffstall J.M. The influence of age and sex on asthma admissions. JAMA 1992, 268:3437-3440.
25. Strachan D.P., Butland B.K., Andersin H.R. Incidence and prognosis of asthma and wheezing illness from early childhood to age 33 in a national British cohort. BMJ 1996, 312:1195-1199.
26. Becklake M.R., Kauffmann F. Gender differences in airway behaviour over the human life span. Thorax 1999, 54:1119-1138.
27. De Marco R., Locatelli F., Sunyer J., Burney P. Differences in incidence of reported asthma related to age in men and women. A retrospective analysis of the data of the European Respiratory Health Survey. Am J Respir Crit Care Med 2000, 162:68-74.
28. Lim R.H., Kobzik L. Sexual tension in the airways. The puzzling duality of estrogen in asthma. Editorial Am J Respir Cell Mol Biol 2008, 38:499-500.
29. Salam M.T., Wenten M., Gilliland F.D. Endogenous and exogenous sex steroid hormones and asthma and wheeze in young women. JAllergy Clin Immunol 2006, 117:1001-1007.
30. Macsali F., Real F.G., Plana E., Sunyer J., Anto J., Dratva J., et al. Early age at menarche, lung function, and adult asthma. Am J Respir Crit Care Med 2011, 183:8-14.
31. Prescott E., Lange P., Vestbo J. Effect of gender on hospital admission for asthma and prevalence of self-reported asthma: a prospective study based on a sample of the general population. Copenhagen city heart study group. Thorax 1997, 53:387-389.
32. Chen Y., Stewart P., Johansen H., McRae L., Taylor G. Sex difference in hospitalization due to asthma in relation to age. JClin Epidemiol 2003, 56:180-187.
33. Rees L. An aetiological study of premenstrual asthma. JPsychosom Res 1963, 7:191-197.
34. Hanley S.P. Asthma variation with menstruation. Br J Dis Chest 1981, 75:306-308.
35. Chandler M.H.H., Schuldheisz S., Phillips B.A., Muse K.N. Premenstrual asthma: the effect of estrogen on symptoms, pulmonary function, and beta-2 receptors. Pharmacotherapy 1997, 17:224-234.
36. Gibbs C.J., Coutts, Lock R., Finnegan O.C., White R.J. Premenstrual exacerbation of asthma. Thorax 1984, 39:833-836.
37. Murphy V.E., Gibson P.G. Premenstrual asthma: prevalence, cycle-to-cycle variability, and relationship to oral contraceptive use and menstrual symptoms. JAsthma 2008, 45:696-704.
38. Pereira-Vega A., Sanchez J.L., Gil F.L., Maldonado J.A., Bravo J.M., Ignacio J.M., et al. Premenstrual asthma and symptoms related to premenstrual syndrome. JAsthma 2010, 47:835-840.
39. Skobeloff E.M., Spivey W.H., Silverman R.A., Eskin B.A., Harchelroad F.P., Alessi T.V. The effect of the menstrual cycle on asthma presentations in the emergency department. Arch Intern Med 1996, 156:1837-1840.
40. Svanes C., Real F.G., Gislason T., Jansson C., Jogi R., Norman E., et al. Association of asthma and hay fever with irregular menstruation. Thorax 2005, 60:445-450.
41. Gomez Real F., Svanes C., Reidar Omenaas E., Antò J.M., Plana E., Janson C., et al. Menstrual irregularity and lung function. JAllergy Clin Immunol 2007, 120:557-564.
42. Schatz M., Harden K., Firsythe A., Chilingar L., Hoffman C., Sperling W., et al. The course of asthma during pregnancy, post-partum, and with successive pregnancies: a prospective analysis. JAllergy Clin Immunol 1988, 81:509-517.
43. Juniper E.F., Daniel E.E., Roberts R.S., Kline P.A., Hargreave F.E., Newhouse M.T. Improvement in airway responsiveness and asthma severity during pregnancy: a prospective study. Am Rev Respir Dis 1989, 140:924-931.
44. Kwon H.L., Triche E.W., Belanger K., Bracken M.B. The epidemiology of asthma during pregnancy: prevalence, diagnosis, and symptoms. Immunol Allergy Clin North Am 2006, 26:29-62.
45. Ali Z., Ulrik C.S. Incidence and risk factors for exacerbations of asthma during pregnancy. JAsthma Clinical Allergy 2013, 6:53-60.
46. Amrani Y., Syed F., Huang C., Li K., Liu V., Jain D., et al. Expression and activation of the oxytocin receptor in airway smooth muscle cells: regulation by TNF-α and IL-13. Respir Res 2010, 11:104.
47. Levin E.R. Minireview: extranuclear steroid receptors: roles in modulation of cell functions. Mol Endocrinol 2011, 25:377-384.
48. Ellmann S., Sticht H., Thiel F., Beckmann M.W., Strick R., Strissel P.L. Estrogen and progesterone receptors: from molecular structures to clinical targets. Cell Mol Life Sci 2009, 66:2405-2426.
49. Giannopoulos G., Smith S.K. Androgen receptors in fetal rabbit lung and the effect of fetal sex on the levels of circulating hormones and pulmonary hormone receptors. JSteroid Biochem 1982, 17:461-465.
50. Couse J.F., Lindzey J., Grandien K., Gustafsson J.A., Korach K.S. Tissue distribution and quantitative analysis of estrogen receptor-alpha (ERalpha) and estrogen receptor-beta (ERbeta) messenger ribonucleic acid in the wild-type and ERalpha-knockout mouse. Endocrinology 1997, 138:4613-4621.
51. Townsend E.A., Meuchel L.W., Thompson M.A., Pabelik C.M., Prakash Y.S. Estrogen increases nitric-oxide production in human bronchial epithelium. JPharmacol Exp Ther 2011, 339:815-824.
52. Ivanova M.M., Mazhawidza W., Dougherty S.M., Minna J.D., Klinge C.M. Activity and intracellular location of estrogen receptors α and β in human bronchial epithelial cells. Mol Cell Endocrinol 2009, 305:12-21.
53. Massaro D., Massaro G.D. Estrogen receptor regulation of pulmonary alveolar dimensions: alveolar sex dimorphism in mice. Am J Physiol Lung Cell Mol Physiol 2006, 290:L866-L870.
54. Tam A., Morrish D., Wadsworth S., Dorscheid D., Man S.F.P., Sin D.D. The role of female hormones on lung function in chronic lung diseases. BMC Women's Health 2011, 11(24):1-29.
55. Carey M.A., Card J.W., Bradbury J.A., Moorman M.P., Haykal-Coates N., Gavett S.H., et al. Spontaneous airway hyperresponsiveness in estrogen receptor-alpha-deficient mice. Am J Respir Crit Care Med 2007, 175:126-135.
56. Gomez Real F., Svanes C., Macsali F., Omenaas R. Hormonal factors and respiratory health in women - a review. Clin Respir J 2008, 2:111-119.
57. Hisamoto K., Ohmichi M., Kurachi H., Hayakawa J., Kanda Y., Nishio Y., et al. Estrogen induces the Akt-dependent activation of endothelial nitric-oxide synthase in vascular endothelial cells. JBiol Chem 2001, 276:3459-3467.
58. Shaul P.W. Rapid activation of endothelial nitric oxide synthase by estrogen. Steroids 1999, 64:28-34.
59. Dimitropoulou C., Drakopanagiotakis F., Catravas D. Estrogens as a new therapeutic target for asthma and chronic obstructive pulmonary disease. Drug News Perspect 2007, 20:241-252.
60. Dimitropoulou C., White R.E., Ownby D.R., Catravas J.D. Estrogen reduces carbachol-induced constriction of asthmatic airways by stimulating large-conductance voltage and calcium-dependent potassium channels. Am J Respir Cell Mol Biol 2005, 32:239-247.
61. Intapad S., Dimitropoulou C., Snead C., Piyachaturawat P., Catravas J.D. Regulation of asthmatic airway relaxation by estrogen and heat shock protein 90. JCell Physiol 2012, 227:3036-3043.
62. Townsend E.A., Satish V., Thompson M.A., Pabelik C.M., Prakash Y.S. Estrogen effects on human airway smooth muscle involve cAMP and protein kinase A. Am J Physiol Lung Cell Mol Physiol 2012, 303:L923-L928.
63. Russel K.S., Haynes M.P., Sunha D., Clerisme E., Bender J.R. Human vascular endothelial cells contain membrane binding sites for estradiol, which mediate rapid intracellular signalling. Proc Natl Acad Sci USA 2000, 97:5930-5935.
64. Cohen P.G. Estradiol induces inhibition of 11β-hydroxysteriod dehydrogenase 1: an explanation for the postmenopausal hormone replacement therapy effects. Med Hypotheses 2005, 64:989-991.
65. Simoes D.C., Psarra A.-M.G., Mauad T., Pantou I., Roussos C., Sekeris C., et al. Glucocorticoid and estrogen receptors are reduced in mitochondria of lung epithelial cells in asthma. PloS ONE 2012, 7:1-12.
66. Ligieiro de Oliveira A.P., Domingos H.V., Cavriani G., Damazo A.S., dos Santos Franco A.L., Oliani S.M., et al. Cellular recruitment and cytokine generation in a rat model of allergic lung inflammation are differently modulated by progesterone and estradiol. Am J Physiol Cell Physiol 2007, 293:C1120-C1128.
67. Melgert B.N., Postma D.S., Kuipers I., Geerlings M., Luinge M.A., van der Strate B.W., et al. Female mice are more susceptible to the development of allergic airway inflammation than male mice. Clin Exp Allergy 2005, 35:1496-1503.
68. Cai Y., Webb D.C. Estrogen stimulates Th2 cytokine production and regulates the compartimentalisation of eosinophils during allergic challenge in a mouse model of asthma. Int Arch Allergy Immunol 2012, 158:252-260.
69. Zierau O., Zenclussen A.C., Jensen F. Role of female sex hormones, estradiol and progesterone, in mast cell behavior. Front Immunol 2012, 3:156. 10.3389/fimmu.2012.00169.
70. Bonds R.S., Midoro-Horiuti T. Estrogen effects in allergy and asthma. Curr Opin Allergy Clin Immunol 2013, 13:92-99.
71. Uemura Y., Liu T.Y., Narita Y., Suzuki M., Matsushita S. Beta-estradiol (E2) plus tumor necrosis factor-alpha induces a distorted maturation of human monocyte derived dendritic cells and promotes their capacity to initiate T-helper 2 responses. Hum Immunol 2008, 69:149-157.
72. Troisi R.J., Speizer F.E., Willett W.C., Trichopoulos D., Rosner B. Menopause, postmenopausal estrogen preparations, and the risk of adult-onset asthma. A prospective cohort study. Am J Respir Crit Care Med 1995, 152:1183-1188.
73. Gomez Real F., Björnsson E.H., Frankiln K., Gislason D., Gislason T., Gulsvik A., et al. Hormone replacement therapy, body mass index and asthma in perimenopausal women: a cross sectional survey. Thorax 2006, 61:34-40.
74. Gomez Real F., Svanes C., Omenaas E.R., Antò J.M., Plana E., Jarvis D., et al. Lung function, respiratory symptoms, and the menopausal transition. JAllergy Clin Immunol 2008, 121:72-80.
75. Balzano G., Fuschillo S., De Angelis E., Gaudiosi C., Mancini A., Caputi M. Persistent airway inflammation and high exacerbation rate in asthma that starts at menopause. Monaldi Arch Chest Dis 2007, 67:135-141.
76. Zemp E., Schikowski T., Dratyva J., Schindler C., Probst-Hensch N. Asthma and the menopause: a systematic review and meta-analysis. Maturitas 2012, 73:212-217.
77. Foschino Barbaro M.P., Costa V.R., Resta O., Prato R., Spanevello A., Palladino G.P., et al. Menopausal asthma: a new biological phenotype?. Allergy 2010, 65:1306-1312.
78. Jarvis D., Leynaert B. The association of asthma, atopy and lung function with hormone replacement therapy and surgical cessation of menstruation in a population-based sample of English women. Allergy 2008, 63:95-102.
79. Key T.J., Pike M.C., Brown J.B., Hermon C., Allen D.S., Wang D.Y. Cigarette smoking and urinary oestrogen excretion in premenopausal and postmenopausal women. Br J Cancer 1996, 74:1313-1316.
80. Lieberman D., Kopernik G., Porath A., Lazer S., Heimer D. Sub-clinical worsening of bronchial asthma during estrogen replacement therapy in asthmatic post-menopausal women. Maturitas 1995, 21:153-157.
81. Barr R.G., Wentowski C.C., Grodstein F., Somers S.C., Stampfer M.J., Schwartz J., et al. Prospective study of postmenopausal hormone use and newly diagnosed asthma and chronic obstructive pulmonary disease. Arch Intern Med 2004, 164:379-386.
82. Romieu I., Fabre A., Fournier A., Kauffmann F., Varraso R., Mesrine S., et al. Postmenopausal hormone therapy and asthma onset in the E3N cohort. Thorax 2009, 65:292-297.
83. Hepburn M.C., Dooley D.P., Morris M.J. The effects of estrogen replacement therapy on airway function in postmenopausal, asthmatic women. Arch Intern Med 2011, 161:2717-2720.
84. Carlson C.L., Cushman M., Enright P.L., Cauley J.A., Newman A.B. Hormone replacement therapy is associated with higher FEV1 in elderly women. Am J Respir Crit Care Med 2001, 163:423-428.
85. Pata Ö. The effects of hormone replacement therapy type on pulmonary function in postmenopausal women. Maturitas 2003, 213-218.
86. Cevrioglu A.S., Fidan F., Unlu M., Yilmazer M., Oman A., Fenkci I.V., et al. The effects of hormone therapy on pulmonary function tests in postmenopausal women. Maturitas 2004, 49:221-227.